Metabolic and other morbid complications in congenital generalized lipodystrophy type 4
Gülçin Akıncı(Izmir University), Abhimanyu Garg(Southwestern Medical Center), Partha Pratim Chakraborty(KPC Medical College and Hospital), Ümit Çavdar(Dokuz Eylül University), Özlem Akgün Doğan(Acıbadem University), Saif Al-Yaarubi(Oman Medical College), Barış Akıncı(Dokuz Eylül University), Vinaya Simha(Mayo Clinic), İlgın Yıldırım Şimşir(Ege University), Aisha Al Senani(Royal Hospital), Rebecca J. Brown(National Institutes of Health), Azza Al‐Shidhani(Oman Medical College), Funmbi Babalola(Hospital for Sick Children), Nancy Gagné(Centre Hospitalier Universitaire de Sherbrooke), Elif A Oral(University of Michigan), Thomas Scherer(Medical University of Vienna), Madhumati S. Vaishnav(Samatvam Endocrinology Diabetes Centre), Başak Özgen Saydam(Dokuz Eylül University), Nil Çomunoğlu(Istanbul University-Cerrahpaşa), Beyhan Tüysüz(Istanbul University-Cerrahpaşa), Ekaterina Sorkina(Newcastle upon Tyne Hospitals NHS Foundation Trust), Marianna Beghini(Medical University of Vienna), Kavitha Muniraj(Samatvam Endocrinology Diabetes Centre), Solaf M. Elsayed(Ain Shams University Hospital), Nivedita Patni(Southwestern Medical Center), Ashwaq Al Maimani(Genetic Resources Center), Clemens Kamrath(Justus-Liebig-Universität Gießen), Moosa Allawati(Royal Hospital), Haluk Topaloğlu(Yeditepe University), Flavia Prodam(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Martin Wabitsch(Universität Ulm), Tea Huseinbegovic(Southwestern Medical Center), Aliya Al Hosin(Genetic Resources Center), J. E. Curtis(Hospital for Sick Children), Ahmed Hamed(Royal Hospital), Ender Can(Gaziantep Children's Hospital), Nadia Alhashmi(Royal Hospital), Fatma Dursun(Ümraniye Eğitim ve Araştırma Hastanesi)
Cited by 14
Related Papers
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
|Nature Genetics|2002|518
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
|Nature Communications|2013|298
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292